| Jennifer Nicole Brewer, PA-C | |
|
1601 New Castle Rd, Forrest City, AR 72335-2218 | |
| (870) 261-0000 | |
| Not Available |
| Full Name | Jennifer Nicole Brewer |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 12 Years |
| Location | 1601 New Castle Rd, Forrest City, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891034047 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 3014 (Tennessee) | Primary |
| 363AM0700X | Physician Assistant - Medical | 3014 (Tennessee) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wellmont Bristol Regional Medical Center | Bristol, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Watauga Orthopaedics Plc | 1456246479 | 62 |
News Archive
CDKL5 Deficiency Disorder is a devastating neurodevelopmental disorder caused by mutations in the CDKL5 gene.
Clementia Pharmaceuticals, Inc. today announced that it has secured an additional $10 million from current investors to support development of the company's lead compound palovarotene for the treatment of fibrodysplasia ossificans progressive (FOP).
Boehringer Ingelheim Pharmaceuticals, Inc. and Duke Clinical Research Institute have formed a unique collaborative relationship to uncover insights into idiopathic pulmonary fibrosis (IPF), a progressive and fatal lung disease.
IntelliDose®, a leading clinical software to manage medical oncology practices, today introduces IntelliScribe™ – a new, fully integrated module in the IntelliDose workflow – to electronically generate prescriptions at any point in the chemotherapy order writing process.
An investigational drug to treat Type 2 diabetes, empagliflozin, lowers blood pressure in patients with Type 2 diabetes and hypertension (high blood pressure), a new study finds. The results were presented Sunday in a late-breaking abstract at the joint meeting of the International Society of Endocrinology and The Endocrine Society: ICE/ENDO 2014 in Chicago.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Nicole Brewer, PA-C 75 Booker Dr, Lonoke, AR 72086-9163 Ph: (865) 310-6855 | Jennifer Nicole Brewer, PA-C 1601 New Castle Rd, Forrest City, AR 72335-2218 Ph: (870) 261-0000 |
News Archive
CDKL5 Deficiency Disorder is a devastating neurodevelopmental disorder caused by mutations in the CDKL5 gene.
Clementia Pharmaceuticals, Inc. today announced that it has secured an additional $10 million from current investors to support development of the company's lead compound palovarotene for the treatment of fibrodysplasia ossificans progressive (FOP).
Boehringer Ingelheim Pharmaceuticals, Inc. and Duke Clinical Research Institute have formed a unique collaborative relationship to uncover insights into idiopathic pulmonary fibrosis (IPF), a progressive and fatal lung disease.
IntelliDose®, a leading clinical software to manage medical oncology practices, today introduces IntelliScribe™ – a new, fully integrated module in the IntelliDose workflow – to electronically generate prescriptions at any point in the chemotherapy order writing process.
An investigational drug to treat Type 2 diabetes, empagliflozin, lowers blood pressure in patients with Type 2 diabetes and hypertension (high blood pressure), a new study finds. The results were presented Sunday in a late-breaking abstract at the joint meeting of the International Society of Endocrinology and The Endocrine Society: ICE/ENDO 2014 in Chicago.
› Verified 9 days ago
Rodneysha Martin, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 1220 N Washington St, Forrest City, AR 72335 Phone: 870-594-6001 Fax: 501-823-3623 |